| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80061 |
Lipid panel |
1,505 |
1,497 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,317 |
1,158 |
$0.00 |
| 82540 |
|
366 |
363 |
$0.00 |
| 86703 |
|
189 |
189 |
$0.00 |
| 3078F |
|
387 |
368 |
$0.00 |
| 82274 |
|
266 |
266 |
$0.00 |
| 86480 |
|
12 |
12 |
$0.00 |
| 85610 |
|
33 |
24 |
$0.00 |
| 99442 |
|
89 |
86 |
$0.00 |
| 3077F |
|
38 |
37 |
$0.00 |
| 83540 |
|
27 |
27 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
16 |
$0.00 |
| 77062 |
|
27 |
27 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
27 |
27 |
$0.00 |
| 86705 |
|
12 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
23 |
12 |
$0.00 |
| 82728 |
|
26 |
26 |
$0.00 |
| 99443 |
|
54 |
51 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
562 |
547 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,528 |
3,118 |
$0.00 |
| 82043 |
|
366 |
363 |
$0.00 |
| 3074F |
|
334 |
323 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
469 |
467 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
777 |
756 |
$0.00 |
| 85027 |
|
233 |
219 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
397 |
395 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,554 |
1,473 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,782 |
1,768 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,226 |
1,158 |
$0.00 |
| 82607 |
|
51 |
50 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
640 |
613 |
$0.00 |
| 81001 |
|
24 |
24 |
$0.00 |
| 90686 |
|
51 |
51 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
39 |
39 |
$0.00 |
| 1111F |
|
111 |
107 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
111 |
109 |
$0.00 |
| 86780 |
|
24 |
24 |
$0.00 |
| 87340 |
|
15 |
15 |
$0.00 |
| 3044F |
|
182 |
181 |
$0.00 |
| 83735 |
|
15 |
12 |
$0.00 |
| 83550 |
|
27 |
27 |
$0.00 |
| 3075F |
|
43 |
42 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
26 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$0.00 |
| 3079F |
|
28 |
27 |
$0.00 |
| 82746 |
|
12 |
12 |
$0.00 |
| 86706 |
|
25 |
25 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
13 |
$0.00 |
| 90656 |
|
28 |
28 |
$0.00 |